case_images: PMC4684617_01
case_images: Intraoperative tissue changes. Figure depicting intraoperative tissue changes identified using the integrated ultrasound imaging transducer of the Sonablate  500 HIFU device. Visualisation of hyperechoic transformation at the target site confirms tissue ablation. a Transverse and sagittal still images of the cervical tumour depicting HIFU treatment planning. b Transverse and sagittal still images of the cervical tumour demonstrating post-ablational hyperechoic effects, signifying effective ablation
case_images: 40349_2015_43_Fig1_HTML.jpg
case_images: PMC4684617_01_40349_2015_43_Fig1_HTML.jpg
case_images: Fig1
case_images: Hyperechoic greyscale changes and gas formation, representing ablative effects, were visualised using the real-time integrated ultrasound imaging to monitor for the presence of tissue destruction (Fig. 1).
case_images: Pre- and post-treatment MRI changes. Axial T2-weighted MRI at the level of the pelvic side wall showing the primary cervical tumour at baseline (a) and post-treatment (b). A significant tumour burden remains, although, the AP length of the lesion has reduced in size from 4.5 to 3.4 cm
case_images: 40349_2015_43_Fig2_HTML.jpg
case_images: PMC4684617_01_40349_2015_43_Fig2_HTML.jpg
case_images: Fig2
case_images: Baseline and post-therapy imaging is shown in Fig. 2.